Clinical Trials List
Protocol NumberUCBI0916
2002-12-01 - 2004-01-01
Phase III
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
0 participants
